The Globe and Mail reports in its Saturday, April 19, edition that Knight Therapeutics ($6.03) chief executive officer Jonathan Goodman (former CEO of Paladin Labs) insists his capacity to make business decisions is "perfectly intact and functioning at a high level. I think, intellectually, I'm as smart as I was." The Globe's Richard Blackwell writes that Mr. Goodman was in seriously bad shape after a fall from a bicycle 2-1/2 years ago. Mr. Blackwell says it is clear that what Mr. Goodman calls his "type A plus" personality is fully intact. He is still competitive and massively self-confident, and he wants things his way. In just a few weeks of existence Knight has raised more than $250-million in private placements -- a testament to Mr. Goodman's reputation for managing a growing drug company. While Knight now has loads of cash, and plans to acquire the rights to sell many more drugs, the firm has only one other employee, chief financial officer Jeffrey Kadanoff, whom Mr. Goodman hired on day one. Investors appear to think Mr. Goodman can turn Knight into another Paladin Labs. Knight stock has risen by more than 50 per cent since its first day of trading in early March.